U.S. Online Retail and Ecommerce Stock News

NasdaqGS:METC
NasdaqGS:METCMetals and Mining

Is It Too Late To Consider Ramaco Resources (METC) After A 102% One-Year Surge?

If you are wondering whether Ramaco Resources at around US$18.64 is still offering value or starting to look stretched, you are not alone. The stock has delivered a 101.8% return over the last year and a very large gain over five years, even though the 7 day return of a 15.6% decline and the year to date return of a 0.4% decline suggest recent trading has been more muted. Recent coverage has focused on Ramaco Resources as investors reassess coal names and related materials stocks, with...
NasdaqGS:NXST
NasdaqGS:NXSTMedia

Nexstar Holds Dividend While Advancing TEGNA Deal And FCC Approvals

Nexstar Media Group kept its quarterly dividend unchanged while preparing financing for its pending acquisition of TEGNA. The company is directing excess cash toward the TEGNA deal and debt reduction rather than raising the dividend. Nexstar has filed FCC applications for broadcast license transfers and requested related regulatory waivers as part of the transaction process. Nexstar Media Group, NasdaqGS:NXST, is holding its quarterly dividend steady even as it advances work on the TEGNA...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

US Stock Market Today: S&P 500 Futures Edge Higher On Factory Rebound And Firm Yields

The Morning Bull - US Market Morning Update Tuesday, Feb, 3 2026 US stock futures are slightly higher this morning, with E mini S&P 500 contracts up about 0.2% to 0.3%, as investors weigh stronger factory activity against steady borrowing costs. The ISM Manufacturing PMI registered 52.6 in January 2026, its first expansion in a year, which signals factories are getting busier and hiring is improving. A similar score of 52.4 from the S&P Global US Manufacturing PMI points to firmer demand but...
NasdaqGS:DVAX
NasdaqGS:DVAXBiotechs

Assessing Dynavax Technologies (DVAX) Valuation After Recent Share Price Momentum And Ongoing Pipeline Investment

Key snapshot of Dynavax Technologies Dynavax Technologies (DVAX) has drawn investor attention recently as its shares trade around $15.49, with returns roughly flat over the past month and a gain over the past 3 months. The commercial stage vaccine maker reports annual revenue of about US$330.514 million and a net loss of roughly US$43.401 million, giving investors a mix of established product sales and ongoing investment in its pipeline. See our latest analysis for Dynavax Technologies. While...